The Food and Drug Administration has granted accelerated approval to vosoritide (Voxzogo) to treat children ages five years and older with achondroplasia who still have open epiphyses.Children prescribed vosoritide should have a meal and 240 to 300 mL of fluid in the hour prior to drug administration to prevent hypotensive episodes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/01.NAJ.0000822964.26069.7e | DOI Listing |
Publication Analysis
Top Keywords
drug administration
8
drug treats
4
treats pediatric
4
pediatric achondroplasia
4
achondroplasia food
4
food drug
4
administration granted
4
granted accelerated
4
accelerated approval
4
approval vosoritide
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!